Literature DB >> 26249017

Method development for the determination of 24S-hydroxycholesterol in human plasma without derivatization by high-performance liquid chromatography with tandem mass spectrometry in atmospheric pressure chemical ionization mode.

Hiroshi Sugimoto1, Masaaki Kakehi1, Yoshinori Satomi2, Hidenori Kamiguchi2, Fumihiro Jinno1.   

Abstract

We developed a highly sensitive and specific high-performance liquid chromatography with tandem mass spectrometry method with an atmospheric pressure chemical ionization interface to determine 24S-hydroxycholesterol, a major metabolite of cholesterol formed by cytochrome P450 family 46A1, in human plasma without any derivatization step. Phosphate buffered saline including 1% Tween 80 was used as the surrogate matrix for preparation of calibration curves and quality control samples. The saponification process to convert esterified 24S-hydroxycholesterol to free sterols was optimized, followed by liquid-liquid extraction using hexane. Chromatographic separation of 24S-hydroxycholesterol from other isobaric endogenous oxysterols was successfully achieved with gradient mobile phase comprised of 0.1% propionic acid and acetonitrile using L-column2 ODS (2 μm, 2.1 mm id × 150 mm). This assay was capable of determining 24S-hydroxycholesterol in human plasma (200 μL) ranging from 1 to 100 ng/mL with acceptable intra- and inter-day precision and accuracy. The potential risk of in vitro formation of 24S-hydroxycholesterol by oxidation from endogenous cholesterol in human plasma was found to be negligible. The stability of 24S-hydroxycholesterol in relevant solvents and human plasma was confirmed. This method was successfully applied to quantify the plasma concentrations of 24S-hydroxycholesterol in male and female volunteers.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  24S-Hydroxycholesterol; Atmospheric pressure chemical ionization; Chromatographic separation; Saponification; Surrogate matrices

Mesh:

Substances:

Year:  2015        PMID: 26249017     DOI: 10.1002/jssc.201500719

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  1 in total

1.  Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice.

Authors:  Toshiya Nishi; Shinichi Kondo; Maki Miyamoto; Sayuri Watanabe; Shigeo Hasegawa; Shigeru Kondo; Jason Yano; Etsurou Watanabe; Tsuyoshi Ishi; Masato Yoshikawa; Haruhi Kamisaki Ando; William Farnaby; Shinji Fujimoto; Eiji Sunahara; Momoko Ohori; Matthew J During; Takanobu Kuroita; Tatsuki Koike
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.